Terms: = Bone cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Treatment
47 results:
1. Bioinformatics Analysis of the Genetic and Epigenetic Alterations of bone Morphogenetic Protein Receptors in Metastatic Breast cancer.
Hermawan A; Putri H
Biochem Genet; 2024 Apr; 62(2):594-620. PubMed ID: 37486509
[TBL] [Abstract] [Full Text] [Related]
2. bone metastatic cancer of unknown primary at initial presentation.
Matsuoka M; Onodera T; Yokota I; Iwasaki K; Suzuki Y; Masanari H; Kondo E; Iwasaki N
Clin Transl Oncol; 2024 Feb; 26(2):461-467. PubMed ID: 37395989
[TBL] [Abstract] [Full Text] [Related]
3. FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells.
Quist-Løkken I; Andersson-Rusch C; Kastnes MH; Kolos JM; Jatzlau J; Hella H; Olsen OE; Sundan A; Knaus P; Hausch F; Holien T
Cell Commun Signal; 2023 Jan; 21(1):25. PubMed ID: 36717825
[TBL] [Abstract] [Full Text] [Related]
4. Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial.
Meduri B; Baldissera A; Iotti C; Scheijmans LJEE; Stam MR; Parisi S; Boersma LJ; Ammendolia I; Koiter E; Valli M; Scandolaro L; Busz D; Stenfert Kroese MC; Ciabatti S; Giacobazzi P; Ruggieri MP; Engelen A; Munafò T; Westenberg AH; Verhoeven K; Vicini R; D'Amico R; Lohr F; Bertoni F; Poortmans P; Frezza GP
J Clin Oncol; 2023 Apr; 41(12):2201-2210. PubMed ID: 36623246
[TBL] [Abstract] [Full Text] [Related]
5. Clinical risk factors for severity and prognosis of antiresorptive agent-related osteonecrosis of the jaw: a retrospective observational study.
Nashi M; Hirai T; Iwamoto T; Takenobu T
J Bone Miner Metab; 2022 Nov; 40(6):1014-1020. PubMed ID: 36166107
[TBL] [Abstract] [Full Text] [Related]
6. Application of Endoprosthetic Replacement in Old Patients with Isolated Proximal Femoral bone Metastases.
Liu P; Wang Z; Zhang S; Ding G; Tan K; Zhou J
Ann Surg Oncol; 2022 Dec; 29(13):8623-8630. PubMed ID: 35606471
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real-life data.
Gürbüz M; Doğan İ; Akkuş E; Ermiş H; Utkan G; Vatansever S; Taş F
Dermatol Ther; 2021 Nov; 34(6):e15122. PubMed ID: 34478210
[TBL] [Abstract] [Full Text] [Related]
8. mTOR inhibitors reduce enteropathy, intestinal bleeding and colectomy rate in patients with juvenile polyposis of infancy with PTEN-bmpr1a deletion.
Taylor H; Yerlioglu D; Phen C; Ballauff A; Nedelkopoulou N; Spier I; Loverdos I; Busoni VB; Heise J; Dale P; de Meij T; Sweet K; Cohen MC; Fox VL; Mas E; Aretz S; Eng C; Buderus S; Thomson M; Rojas I; Uhlig HH
Hum Mol Genet; 2021 Jun; 30(14):1273-1282. PubMed ID: 33822054
[TBL] [Abstract] [Full Text] [Related]
9. Human osteoarthritis cartilage-derived stromal cells activate joint degeneration through TGF-beta lateral signaling.
Liu W; Feng M; Jayasuriya CT; Peng H; Zhang L; Guan Y; Froehlich JA; Terek RM; Chen Q
FASEB J; 2020 Dec; 34(12):16552-16566. PubMed ID: 33118211
[TBL] [Abstract] [Full Text] [Related]
10. Which Factors Affect Survival in Patients With Upper Limb Osteosarcoma?
Restrepo DJ; Huayllani MT; Boczar D; Sisti A; Spaulding AC; Carter RE; Moran SL; Parker AS; Perdikis G; Forte AJ
Anticancer Res; 2019 Sep; 39(9):5027-5031. PubMed ID: 31519610
[TBL] [Abstract] [Full Text] [Related]
11. Role of zoledronic acid in nasopharyngeal carcinoma patients with bone-only metastasis at diagnosis.
Sun XS; Lin C; Liang YJ; Chen QY; Tang LQ; Mai HQ
Oral Oncol; 2019 Oct; 97():31-36. PubMed ID: 31421468
[TBL] [Abstract] [Full Text] [Related]
12. Aplastic anemia associated with Crohn's disease: a tertiary center retrospective study.
Su S; Liu Z; Wang F; Zhang Y; Chu Y; Jiang M; Xu B; Wu N; Lin J; Xue X; Shi Y; Yang S; Wu K; Liang J
Ann Hematol; 2019 Sep; 98(9):2053-2061. PubMed ID: 31256218
[TBL] [Abstract] [Full Text] [Related]
13. Clinical characteristics, treatment pattern, and medical costs associated with metastatic castration-resistant prostate cancer in Chinese tertiary care hospital settings.
Qian Z; Wang Y; Tang Z; Ren D; Wang Z; Chen W; Li Z
J Med Econ; 2019 Aug; 22(8):728-735. PubMed ID: 30913930
[No Abstract] [Full Text] [Related]
14. A new signaling cascade linking BMP4, bmpr1a, ΔNp73 and NANOG impacts on stem-like human cell properties and patient outcome.
Voeltzel T; Flores-Violante M; Zylbersztejn F; Lefort S; Billandon M; Jeanpierre S; Joly S; Fossard G; Milenkov M; Mazurier F; Nehme A; Belhabri A; Paubelle E; Thomas X; Michallet M; Louache F; Nicolini FE; Caron de Fromentel C; Maguer-Satta V
Cell Death Dis; 2018 Sep; 9(10):1011. PubMed ID: 30262802
[TBL] [Abstract] [Full Text] [Related]
15. Cytokine sensitivity screening highlights BMP4 pathway signaling as a therapeutic opportunity in ER
Shee K; Jiang A; Varn FS; Liu S; Traphagen NA; Owens P; Ma CX; Hoog J; Cheng C; Golub TR; Straussman R; Miller TW
FASEB J; 2019 Feb; 33(2):1644-1657. PubMed ID: 30161001
[TBL] [Abstract] [Full Text] [Related]
16. bone morphogenetic protein 2 promotes human trophoblast cell invasion by upregulating N-cadherin via non-canonical SMAD2/3 signaling.
Zhao HJ; Klausen C; Li Y; Zhu H; Wang YL; Leung PCK
Cell Death Dis; 2018 Feb; 9(2):174. PubMed ID: 29416020
[TBL] [Abstract] [Full Text] [Related]
17. Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition.
Bosukonda A; Carlson WD
Biochem Soc Trans; 2017 Feb; 45(1):223-228. PubMed ID: 28202676
[TBL] [Abstract] [Full Text] [Related]
18. Abnormal Uterine Bleeding Is Associated With Increased BMP7 Expression in Human Endometrium.
Richards EG; El-Nashar SA; Schoolmeester JK; Keeney GL; Mariani A; Hopkins MR; Dowdy SC; Daftary GS; Famuyide AO
Reprod Sci; 2017 May; 24(5):671-681. PubMed ID: 28142396
[TBL] [Abstract] [Full Text] [Related]
19. The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
Yamada Y; Katsoulakis E; Laufer I; Lovelock M; Barzilai O; McLaughlin LA; Zhang Z; Schmitt AM; Higginson DS; Lis E; Zelefsky MJ; Mechalakos J; Bilsky MH
Neurosurg Focus; 2017 Jan; 42(1):E6. PubMed ID: 28041329
[TBL] [Abstract] [Full Text] [Related]
20. RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways.
Zhang L; Wang P; Qin Y; Cong Q; Shao C; Du Z; Ni X; Li P; Ding K
Oncogene; 2017 Mar; 36(9):1297-1308. PubMed ID: 27617577
[TBL] [Abstract] [Full Text] [Related]
[Next]
